A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
about
The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.An association study between CHEK2 gene mutations and susceptibility to breast cancer.First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer.A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome.CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutationsAssociation of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin LymphomaRapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile AnalysisIdentification, genetic testing, and management of hereditary melanoma.Transposable Elements in Human Cancer: Causes and Consequences of DeregulationAn inherited NBN mutation is associated with poor prognosis prostate cancerA personalised approach to prostate cancer screening based on genotyping of risk founder allelesIncidental copy-number variants identified by routine genome testing in a clinical population.Copy number variations and cancer.The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian populationDNA testing for variants conferring low or moderate increase in the risk of cancer.Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.Inherited mutations in breast cancer genes--risk and response.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Germline copy number variations and cancer predisposition.The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.The genetic epidemiology of prostate cancer and its clinical implications.Progression inference for somatic mutations in cancer.Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?Genetic variants associated with predisposition to prostate cancer and potential clinical implications.The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.The risk of gastric cancer in carriers of CHEK2 mutations.An age-related decrease in factor V Leiden frequency among Polish subjects.Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.CHEK2 mutations and the risk of papillary thyroid cancer.Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.1936A→G (I646 V) polymorphism in the AKAP10 gene encoding A-kinase-anchoring protein 10 in very long-lived poles is similar to that in newborns.Possible counter effect in newborns of 1936A>G (I646V) polymorphism in the AKAP10 gene encoding A-kinase-anchoring protein 10.Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity
P2860
Q33584095-04760BCE-DF44-434D-8BE7-3FAD4653B34EQ33849571-EE37619D-5DA0-4793-AF66-50623736DAEDQ33882010-F6C865E1-A338-48C4-BF29-7CF33553353DQ34077410-E8023F04-4019-42A5-8C51-7C2DD17C207AQ34560743-012957D3-66F7-4E4D-8B71-4CE126AB81F7Q35794421-95AC14D9-673C-4F10-A560-01AF02088CDFQ35823280-F377FA74-5F40-4037-93EB-084FECA40585Q36303818-00FE63DE-6D23-4B28-94D9-CD5E9A45F7F7Q36304955-D13A5140-9C9F-4E6D-A0C6-AECF6EF20D6FQ36362814-B580A95D-6D08-439F-940F-12F2FD12CA0DQ36594121-30DF45BB-6ADE-414B-AC7A-2B2EE0FB8F58Q36959139-162514BE-26EE-4CC9-A0F1-2FDB7B6C193CQ36995191-8904AE96-8CBE-4DFE-8B29-FF03ED0D5A84Q37245547-3D30BBFB-560B-459D-94ED-12A8925A7264Q37262027-A7916F54-72A7-47C6-A40D-9AF67D9B2173Q37327200-95AEF731-F28A-44B3-B8A4-A8A3B1E87F35Q37474516-CBD2B315-83F7-49F0-9AB8-7CDCEBE124BEQ37710564-B49E0C31-0D66-42AF-9DEB-5625990447A8Q37861028-7AA47578-E5ED-44D4-8143-484F6E1B3DD4Q37972706-EFF173F7-6B81-4A2F-9182-7A05D9F6608DQ38003668-8ECE0B88-4DE5-4ED8-BACD-156A188A5C92Q38151415-2EBA8D3B-D02F-46BB-8F22-AEF0EF069FE7Q38168060-EEF89220-4CA3-4FEF-901A-AF009C5BFE80Q38793244-E5E98DC4-F620-445B-B836-56CDE68CA593Q40821559-F24C9479-B111-42AE-B6F9-143E72AC1E1EQ43415543-A117DFA9-14E9-4E24-BDA7-2079FE72B4FDQ44733776-41CDD3FA-CC4A-47C7-9074-23D6A04D02EFQ45259012-A9C4B27D-8EFA-4E1A-BF8C-920EC7BF9F22Q51546713-473BBB86-C023-4046-80D5-263FB4CD6624Q52586097-09408936-B2C1-44D8-86B7-2C3C7A938123Q52976068-90517ADE-E4AD-4FFF-823C-28817221E5FDQ53286223-990D0A70-244F-46BA-818E-244EF8ED87F6Q54286394-06F8AEB1-9543-4367-B7FC-4C823D10C6A7Q54579342-34A4724B-F72F-470C-B7D7-83DCD4FFDF05Q58797665-21B130BA-7175-4042-B408-55E22C7519D9
P2860
A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A large germline deletion in t ...... eased risk of prostate cancer.
@en
type
label
A large germline deletion in t ...... eased risk of prostate cancer.
@en
prefLabel
A large germline deletion in t ...... eased risk of prostate cancer.
@en
P2093
P2860
P50
P356
P1476
A large germline deletion in t ...... eased risk of prostate cancer.
@en
P2093
A Borkowski
A Sikorski
B Gliniewicz
B Małkiewicz
D Godlewski
D Wokołorczyk
J Gronwald
P2860
P304
P356
10.1136/JMG.2006.044974
P407
P577
2006-11-01T00:00:00Z